Skip to main content

Thermo Electron, ProtoNet, Aureus Pharma

Thermo Electron announced the launch of its LTQ FT Ultra, a next-generation hybrid FTICR mass spectrometer. The instrument “analyzes complex matrices and large molecules with independent sub ppm mass accuracy, ultra-high resolution in excess of 750,000 and improved detection circuitry,” the company said this week in a press release.
Equipped with a novel ICR cell design, the Ultra Cell, which improves sensitivity and widens the dynamic range to beyond 4,000, all on LC timescale, the LTQ FT Ultra is suited for top-down and bottom-up proteomics and metabolomics, the company said.

ProtoNet has released its ProtoNet version 4.5, an automatic classification of protein sequences based on a hierarchical clustering method. The new version provides a classification for all proteins and supports TrEMBL entries, the company said last week in a press release.


Aureus Pharma announced it has released its AurSCOPE Kinase Knowledge database containing biological data obtained from scientific journals and patents.

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.